Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 18.05 as of Sunday, July 26, 2026.
Forward PE Ratio (18.05) = Close Price ($63.41) / Consensus Forward EPS ($3.51)
FORWARD PE RATIO
18.05
SECTOR MEDIAN · HEALTHCARE
18.38
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-1.82%
vs the sector median at left
Centene Corp.
Market Cap
$31.31B
Forward PE Ratio
18.05
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Centene Corp. (CNC) | $31.31B | 18.05 |
| Zoetis Inc. (ZTS)vs › | $31.59B | 10.95 |
| Biogen Inc. (BIIB)vs › | $29.85B | 15.59 |
| Medline Inc. (MDLN)vs › | $32.77B | 25.58 |
| ResMed Inc. (RMD)vs › | $28.33B | 17.55 |
| IQVIA Holdings Inc. (IQV)vs › | $34.72B | 16.24 |
| DexCom, Inc. (DXCM)vs › | $27.61B | 27.58 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $27.56B | 12.41 |
| Mettler-Toledo International Inc. (MTD)vs › | $26.82B | 28.44 |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $36.28B | 36.45 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
18.1
consensus next-FY EPS
At today's $63.41 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| 2026-12-31 | $3.51 | $3.45 – $3.66 | 12 | 18.0x |
| 2027-12-31 | $4.52 | $4.01 – $4.78 | 12 | 14.0x |
| 2028-12-31 | $5.96 | $5.10 – $6.81 | 5 | 10.6x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
